Acronis Unveils First Ever AI-powered Cyber Protection Software for Consumers
Acronis Cyber Protect Home Office solution protects data, and devices in a single, innovative offering
SCHAFFHAUSEN, Switzerland, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Acronis, a global cyber protection company, today announced the launch ofAcronis Cyber Protect Home Office (formerly Acronis True Image). The innovative software offers a comprehensive suite of features that seamlessly integrate secure backup, and AI-based security making it the ultimate must-have solution for individuals, families, home office users, and small businesses.
An alarming 41% of individuals rarely or never back up their data while 61% report a preference for an integrated solution. The need for robust, less complex, and all-encompassing backup and cyber protection has never been greater in an increasingly interconnected world. Acronis Cyber Protect Home Office is designed to conquer the evolving landscape of cyber threats by integrating Acronis' cutting-edge cyber protection and secure backup solutions. By combining AI-powered defense mechanisms, robust data backup, remote management tools, and mobile device protection, Acronis sets the standard for holistic cyber protection. Acronis Cyber Protect Home Office is the only complete active-security solution that addresses cyber protection needs within a single, easy-to-use, and modern platform.
“With the advancements of AI, cybercriminals and their tactics are evolving,” said Gaidar Magdanurov, President at Acronis. "Today, even those with limited tech expertise can impact a large number of individuals through the use of complex phishing and social engineering attacks. Protecting data, applications, and systems requires a complete cyber protection solution – integrated with security and data backup. We are excited to announce our latest update of Acronis Cyber Protect Home Office, bringing better performance and stronger security to protect individuals’ data, devices, and home offices."
Key features and benefits of Acronis Cyber Protect Home Office include:
- AI-Based Cybersecurity Enhancement: Innovative AI capabilities proactively identify and neutralize potential threats, while providing an added layer of security against cyberattacks including automated recovery from ransomware attacks. Enable the two-factor authentication (2FA) functionality to maximize your security.
- Backup and Cloning: Acronis Cyber Protect Home Office offers robust secure backup and cloning features. Users can safeguard their critical data and systems with reliable backup that ensures quick recovery in case of data loss or cyber-attacks.
- Remote Management: Users are empowered with remote management tools to monitor and manage their cybersecurity measures from anywhere in the world. This added convenience and flexibility allow for a swift response to any emerging threats.
- Mobile App and Backup: While mobile device manufacturers offer some storage options, it's usually platform-specific, and multi-device families may have a mix of operating systems. Acronis Cyber Protect Home Office features storage capabilities for any operating system and advanced encryption to keep mobile contacts, calendars, photos, files, and data safe. The solution also offers the Acronis mobile app to safeguard mobile device data. The feature seamlessly functions across devices so access data is accessible from anywhere through the app or the web interface.
Acronis Cyber Protect Home Office is available for purchase online and through select resellers with yearly packages starting from $49.99. For more information about features, pricing, and how to get started, please visithttps://go.acronis.com/cyber-protect-home-office.
About Acronis
Acronis unifies data protection and cybersecurity to deliver integrated, automated cyber protection that solves the safety, accessibility, privacy, authenticity, and security (SAPAS) challenges of the modern digital world. With flexible deployment models that fit the demands of service providers and IT professionals, Acronis provides superior cyber protection for data, applications, and systems with innovative next-generation antivirus, backup, disaster recovery, and endpoint protection management solutions powered by AI. With advanced anti-malware powered by cutting-edge machine intelligence and blockchain based data authentication technologies, Acronis protects any environment - from cloud to hybrid to on premises - at a low and predictable cost.
Acronis is a Swiss company, founded in Singapore. Celebrating two decades of innovation, Acronis has more than 2,000 employees in 45 locations. Acronis Cyber Protect solution is available in 26 languages in over 150 countries and is used by 18,000 service providers to protect over 750,000 businesses.
Press contacts:
Karl Bateson
Karl.Bateson@acronis.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/fc283803-76a0-4c44-9b2b-f7bd853b38a7
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
PHAXIAM Therapeutics and Vetophage Announce Strategic Research Collaboration3.10.2023 22:05:00 CEST | Press release
PHAXIAM Therapeutics and Vetophage Announce Strategic ResearchCollaboration Strategic research partnership between PHAXIAM Therapeutics and Vetophage, a biotechnology company specialized in veterinary phage therapy Combining expertise in the research of new phages and phage endolysins that could be applied to human health Exclusive phage and endolysin licensing options in human health for PHAXIAM Therapeutics Lyon (France) and Cambridge (MA, US), October03, 2023 – 10:05pm CEST – PHAXIAM Therapeutics (Nasdaq & Euronext: PHXM) and Vetophage, a company specialized in phage therapy applied to animal health, announce the signature of a long-term strategic research partnership to combine their expertise in the research of new phages and phage-derived proteins (endolysins) in the fight against antimicrobial resistance. Vetophage is a Lyon-based biotechnology company founded in 2017. It develops new tools to detect pathogenic bacteria and alternative solutions to antibiotics based on phages an
Kvika banki hf.: TM Insurance to be sold or listed3.10.2023 21:05:43 CEST | Press release
Following a strategic review at Kvika banki hf. ("Kvika" or "the bank"), the board of directors of Kvika has decided to initiate a process for the sale or listing of its insurance subsidiary TM tryggingar hf. ("TM"). The decision is in line with the bank's vision, where emphasis is placed on simplifying the group's operations and strengthening Kvika's traditional banking activities, in accordance with the bank's goal to increase competition and simplify its customers' finances. Following the divestment of TM, Kvika's main operations will be focused on commercial- and investment banking, along with asset management. It is expected that Kvika's capital base will grow significantly following the divestment of TM, enabling the bank to pursue internal growth opportunities across Kvika's business segments. Increased capital will, among other things, enable the bank to strengthen its market position, in both retail and corporate lending, and increase the risk diversification of its loan book.
Policane® Natural Sweetener Found to Have Low Glycemic Index3.10.2023 20:06:38 CEST | Press release
OCALA, Fla., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Policane®, a natural sweetener made from sugar cane juice in a patented process, has been found to have a low glycemic index (GI) in a study by IFP Suisse SA. According to the study Policane® has a GI of 51.7+/- 3.66. The study also found that Policane® had a 42% lower GI than white sugar. In its conclusion, the study recommends for Policane® a low glycaemic index product classification under International Standard ISO26642. “We are excited to share the results of this study, providing that Policane® is a low-GI sweetener,” said Jorge Enrique Gonzalez, Manager and CEO at PoliCane Co., LLC. “Policane® retains the best parts of the sugar cane stripped away in refined sugar. Policane® is a natural and sustainable sweetener that the world needs.” Policane® is currently produced under license in Costa Rica and can be used in recipes for all sweetened food and beverages, including baked goods, coffee, tea, colas, sauces, ketchup and desserts. Fo
Nokia Corporation: Repurchase of own shares on 03.10.20233.10.2023 20:00:00 CEST | Press release
Nokia Corporation Stock Exchange Release 3 October 2023 at 21:00 EEST Nokia Corporation: Repurchase of own shares on 03.10.2023 Espoo, Finland – On 3 October 2023 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL344,5423.53CEUX39,5413.54AQEU1,3923.53TQEX14,5253.55Total400,0003.53 * Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The second phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 5 April 2022 started on 2 January 2023
Adevinta ASA – Procedures established in response to receipt of non-binding indicative proposal3.10.2023 19:30:00 CEST | Press release
Oslo, 3 October 2023 – Adevinta ASA (“Adevinta” or the “Company”) refers to the stock exchange announcement on 21 September 2023 regarding receipt of a non-binding indicative proposal (the “Proposal”) from a consortium led by Permira and Blackstone, with involvement of the Company’s two main shareholders, regarding a potential offer for all shares of the Company. In response to shareholder enquiries, the Company wants to communicate the procedures it is following in response to the Proposal. Immediately upon receipt of the Proposal, the Company’s board of directors established a special committee comprising the five independent directors on the Company’s board. The special committee is representing the Company in all aspects relating to the Proposal. The directors who are representatives of the three main shareholders of the Company are not involved in the Company’s deliberations and decisions. The independent committee is actively engaging in the Proposal in line with applicable regul